Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Regulatory News (GFRD)

Share Price Information for Galliford Try (GFRD)

Share Price is delayed by 15 minutes
Get Live Data
522.00    -3.00 (-0.57%)
Bid:
524.00
Ask:
526.00
Spread: 2.00 (0.382%)
Market Cap: £512.62m
GFRD Live PriceLast checked at - London Stock Exchange

Intraday Galliford Try Share Chart

AGM Statement

13 Nov 2025 07:00

RNS Number : 3009H
Galliford Try Holdings PLC
13 November 2025
 

 

 

 

 

 

Thursday 13 November 2025

 

GALLIFORD TRY HOLDINGS PLC

 

 

Annual General Meeting Statement and Update on Current Trading

 

Galliford Try Holdings plc, a leading FTSE 250 construction group, is holding its Annual General Meeting (AGM) at 11:00am today, Thursday 13 November 2025 at the offices of Peel Hunt LLP, 100 Liverpool Street, EC2M 2AT.

 

Update on Current Trading and Outlook

 

At our FY25 results in September, we announced another year of continued strategic progress, a fifth consecutive year of strong financial and operational performance, together with an increase in revenue, profit, operating margin and cash.

 

The positive momentum has continued into the new financial year, with the transition from AMP7 to AMP8 continuing as expected over the first half of FY26, and we are trading in line with the Board's full year expectations. On 20 October 2025 we announced our Building business had been appointed to a £3.0bn affordable homes framework by the major Registered Provider, The Hyde Group.

 

On 17 September 2025, the Group launched its third share buyback programme of up to a maximum of £10.0m company shares. As at 10 November 2025 the Group had purchased a total of 297,649 shares, for an aggregate consideration of £1.5m.

 

The Board is confident of meeting its objectives for both the current financial year and in maintaining its progress on the Sustainable Growth Strategy to 2030 - delivering long term value for all our stakeholders. This confidence is underpinned by 92% of projected revenue for the current year and 75% of projected revenue for FY27 already secured. Our strong market position in select sectors - particularly in the water industry - is well aligned with future Government infrastructure spending plans.

 

On 1 October 2025 Galliford Try was included in the FTSE 250 index.

 

For further enquiries please contact:

 

Galliford Try 

Bill Hocking, Chief Executive

Kris Hampson, Chief Financial Officer

Kevin Corbett, General Counsel & Company Secretary

 

 

01895 855001

Teneo

James Macey White/Ffion Dash

 

020 7260 2700

 

The person responsible for making this announcement on behalf of Galliford Try is Kevin Corbett, General Counsel & Company Secretary.

 

 

Note to Editors

 

Galliford Try Holdings plc is a leading UK construction group listed on the London Stock Exchange, and a member of the FTSE 250. Operating as Galliford Try and Morrison Construction, the group carries out building and infrastructure projects with clients in the public, private and regulated sectors across the UK.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMPKBBBABDDDDD
Date   Source Headline
23rd Oct 202410:00 amRNSDirector/PDMR Shareholding
23rd Oct 20247:00 amRNSTransaction in Own Shares
22nd Oct 20247:00 amRNSTransaction in Own Shares
21st Oct 202411:30 amRNSAnnual Financial Report
16th Oct 20241:00 pmRNSDirector/PDMR Shareholding
15th Oct 20247:00 amRNSTransaction in Own Shares
14th Oct 20247:00 amRNSTransaction in Own Shares
11th Oct 202410:30 amRNSDirector/PDMR Shareholding
11th Oct 20247:00 amRNSTransaction in Own Shares
10th Oct 20247:00 amRNSTransaction in Own Shares
9th Oct 20247:00 amRNSTransaction in Own Shares
8th Oct 20243:50 pmRNSDirector/PDMR Shareholding
8th Oct 20243:45 pmRNSDirector/PDMR Shareholding
8th Oct 20243:45 pmRNSDirector/PDMR Shareholding
8th Oct 20247:00 amRNSTransaction in Own Shares
4th Oct 20245:25 pmRNSDirector/PDMR Shareholding
4th Oct 20247:00 amRNSTransaction in Own Shares
3rd Oct 20247:02 amRNSLaunch of Share Buyback Programme
3rd Oct 20247:00 amRNSFinal Results
30th Sep 20243:00 pmRNSTotal Voting Rights
24th Sep 20247:00 amRNSContract
23rd Sep 20247:00 amRNSContract
20th Sep 20248:44 amRNSNotification of Full Year Results
16th Sep 20247:01 amRNS2024 Full Year Results: Revised Publication Date
2nd Sep 20242:30 pmRNSDirector Declaration
2nd Sep 202410:30 amRNSTotal Voting Rights
27th Aug 20244:14 pmRNSBlock listing Interim Review
16th Aug 20249:30 amRNSContract
31st Jul 20244:00 pmRNSTotal Voting Rights
24th Jul 202410:30 amRNSDirector Declaration
23rd Jul 20247:00 amRNSContract
11th Jul 20247:00 amRNSTrading Statement
28th Jun 202411:00 amRNSTotal Voting Rights
13th Jun 20247:00 amRNSContract
31st May 20244:00 pmRNSTotal Voting Rights
31st May 20247:00 amRNSContract
23rd May 20247:00 amRNSCapital Markets Event
30th Apr 20244:00 pmRNSTotal Voting Rights
23rd Apr 20244:00 pmRNSDirector/PDMR Shareholding
10th Apr 20245:00 pmRNSHolding(s) in Company
5th Apr 202411:00 amRNSTotal Voting Rights
28th Mar 20247:00 amRNSDirectorate Change
8th Mar 20244:00 pmRNSDirector/PDMR Shareholding
6th Mar 20247:00 amRNSHalf-year Report
4th Mar 20244:00 pmRNSTotal Voting Rights
1st Mar 20247:00 amRNSDirectorate Change
26th Feb 20246:03 pmRNSBlock listing Interim Review
22nd Feb 20247:00 amRNSContract
17th Jan 20247:00 amRNSTrading Statement
30th Nov 20234:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.